Asset profile

HSK39004

Small molecule

Phase 3underway

Evidence outlook · registrational

Chronic Obstructive Pulmonary Disease: registrational readout pending

Its supporting mid-stage evidence has not yet been graded on this platform. Registrational readout expected around 2027-06-11.

How the evidence outlook works ↗

Upcoming events

(5 total)

Estimated primary-completion dates from ClinicalTrials.gov — registry estimates, never confirmed readout dates; they can move as trials progress.

2026 (1)
August 2026 (1)
Phase 2Chronic Obstructive Pulmonary DiseaseActive not recruiting
Est. primary completion 2026-08-30 · NCT07108699 · CT.gov ↗
What to watch

Research analysis

Source-grounded endpoint goals, benchmarks, comparator context, and caveats for this readout are included with Research.

2027 (4)
June 2027 (1)
Phase 3Chronic Obstructive Pulmonary DiseaseNot yet recruiting
Est. primary completion 2027-06-11 · NCT07658339 · CT.gov ↗
What to watch

Research analysis

Source-grounded endpoint goals, benchmarks, comparator context, and caveats for this readout are included with Research.

July 2027 (1)
Phase 2Chronic Obstructive Pulmonary DiseaseNot yet recruiting
Est. primary completion 2027-07 · NCT07425210 · CT.gov ↗
What to watch

Research analysis

Source-grounded endpoint goals, benchmarks, comparator context, and caveats for this readout are included with Research.

September 2027 (1)
Phase 3Chronic Obstructive Pulmonary DiseaseRecruiting
Est. primary completion 2027-09-30 · NCT07583849 · CT.gov ↗
What to watch

Research analysis

Source-grounded endpoint goals, benchmarks, comparator context, and caveats for this readout are included with Research.

December 2027 (1)
Phase 3Chronic Obstructive Pulmonary DiseaseNot yet recruiting
Est. primary completion 2027-12-24 · NCT07634367 · CT.gov ↗
What to watch

Research analysis

Source-grounded endpoint goals, benchmarks, comparator context, and caveats for this readout are included with Research.

See the full readout calendar ↗

All registered studies

Research

Unlock the complete ClinicalTrials.gov registry

Research includes every linked study, indication filters, phase grouping and featured-trial cross-links.

Competitive landscape

Research

Unlock the competitor landscape

Research compares assets by shared mechanism and indication, including each competitor's stage in the relevant market.